Leonardo Roever: A Consensus Framework for Biomarker Research and Clinical Translation in Stroke
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn about a recent article by Steffen Tiedt et al, published in The Lancet Neurology:
”Biomarkers for Advancing Stroke Diagnosis and Prognosis
The complexity and incomplete understanding of stroke pathophysiology represent substantial challenges for personalized healthcare and the development of new therapies, as reflected in the neutral results of many randomized clinical trials.
Current clinical algorithms lack the precision needed to diagnose stroke before hospital admission, predict disease progression and recovery, or assess the risk of recurrence.
Biomarkers are urgently needed, but the absence of a robust evidence base hinders their clinical translation.
To lay the groundwork for filling this knowledge gap, an international multidisciplinary panel of stroke experts conducted a literature review that formed the basis for a Delphi consensus process.
The stroke expert panel proposes 17 research priorities and five minimum datasets for stroke biomarker studies, each corresponding to a key domain of stroke care: pre-hospital diagnosis, ischemic stroke progression, atrial heart disease, atherosclerotic plaque vulnerability, and intracerebral hemorrhage.
This framework will promote consistency and collaboration for the discovery, validation, and clinical translation of biomarkers to improve stroke care.”
Title: Biomarkers for advancing diagnosis and prognosis in stroke
Authors: Steffen Tiedt, Alejandro Bustamante, Alan Cameron, Pol Camps-Renom, Gerrit M Grosse, Johanna Ospel, Bastian Volbers, Heinrich J Audebert, Julia Aulin, Bastian Cheng, Charlotte Cordonnier, Jonathan M Coutinho, Ana Catarina Fonseca, Michael D Hill, Märit Jensen, Christina Jern, Joseph Kamtchum-Tatuene, Mira Katan, Peter J Kelly, Anna Kopczak, Robin Lemmens, Arne G Lindgren, James J M Loan, Christian H Nolte, Laurent Puy, Luca Saba, Rustam Al-Shahi Salman, Else Charlotte Sandset, Magdy H Selim, Pierre Seners, Nikola Sprigg, Hsin-Hsi Tsai, Karen M Doyle, Joan Montaner, Floris H B M Schreuder, Luciano Sposato, Neshika Samarasekera, John J McCabe on behalf of the BIOSTROKE investigators
Read the Full Article on The Lancet Neurology
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS